Genelux Competitors and Similar CompaniesClear all

ABL Bio's competitors and similar companies include Alchemab Therapeutics.
ABL Bio
ABL Bio
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
Alchemab Therapeutics
Alchemab Therapeutics
Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.
Founding Date
Founding Date
2016
Founding Date
2019
Type
Type
Private
Type
Private
Tags
Locations
Locations
HQ
Locations
London, GB HQ
Babraham, GB
Employees
Employees
615% increase
Employees
512% decrease

Funding

Latest funding round
Latest funding round
$ 65m (almost 8 years ago)
Latest funding round
$ 71.8m (about 5 years ago)
Total funding raised
Total funding raised
$ 90.8m
Total funding raised
$ 71.8m
For sources of this data, please see the company profile

View Company Profiles

Alchemab Therapeutics
HQ
London, GB
Employees
51↓ 2% decrease

Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.

View company